Indivior (INDV)

• Market cap: $1.44B
• 1 day: -2.04%
• 5 days: 10.67%
• 1 month: 20.78%
• 3 months: -5.66%
• 6 months: 23.76%
• Year to date: -7.92%
• 1 year: -34.45%
• 5 years: -49.45%
• 10 years: -49.45%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 8 (+4) [Q4]

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

70% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 23

20% more capital invested

Capital invested by funds: $812M [Q3] → $974M (+$162M) [Q4]

9% more funds holding

Funds holding: 102 [Q3] → 111 (+9) [Q4]

8.62% more ownership

Funds ownership: 53.32% [Q3] → 61.94% (+8.62%) [Q4]

2% more call options, than puts

Call options by funds: $831K | Put options by funds: $811K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $13 13% upside
• Avg. target: $13 13% upside
• High target: $13 13% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Piper Sandler David Amsellem 56% 1-year accuracy 18 / 32 met price target

13% upside $13

Overweight Maintained

6 Mar 2025